Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Giuliana Rizzuto"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Although allogeneic hematopoietic cell transplantation (HCT) represents a curative approach for many patients with hematological diseases, post-transplantation relapse occurs in 20-50% of cases, representing the primary cause of treatment failure and
Externí odkaz:
https://doaj.org/article/ad6aed26b47246a19c50bfae3518e995
Autor:
Giuliana Rizzuto, Federico Mazzon, Chiara Pavoni, Anna Maria Barbui, Silvia Ferrari, Giuseppe Gritti, Anna Grassi, Federico Lussana, Tamara Intermesoli, Alessandro Rambaldi
Publikováno v:
HemaSphere, Vol 7, p e39998b5 (2023)
Externí odkaz:
https://doaj.org/article/6b602d51fc014f6cb0a35fe59ab64483
Autor:
Giuliana Rizzuto, Matteo Leoncin, Silvia Imbergamo, Daniela Taurino, Maria Caterina Mico, Manuela Tosi, Anna Michelato, Ksenija Buklijas, Orietta Spinelli, Federico Lussana, Federica Lessi, Marco Pizzi, Laura Bonaldi, Gianni Binotto, Alessandro Rambaldi, Carmela Gurrieri
Publikováno v:
Clinical Case Reports, Vol 10, Iss 1, Pp n/a-n/a (2022)
Abstract The translocation t(8;9)(p22;p24) results in the production of a chimeric PCM1‐JAK2 fusion protein leading to the constitutive activation of the Janus Kinase 2 that renders this disease potentially sensitive to ruxolitinib. Here, we report
Externí odkaz:
https://doaj.org/article/d50e9d6c5d4847dcb99c79bb273a8c62
Autor:
Theodoros P. Vassilakopoulos, Athanasios Liaskas, Giuliana Rizzuto, Argyrios Symeonidis, Marzia Palma, Maria K. Angelopoulou, Chara Giatra, Flora Kondopidou, Maria Dimou, Alberto Musseti, Ioanna Xagoraris, Marina Siakantaris, Evgenia Verigou, Fotios Panitsas, John Asimakopoulos, Maria Arapaki, Chrysovalantou Chatzidimitriou, Marina Belia, Sotirios Sachanas, Penelope Korkolopoulou, Antonello Cabras, Eleni Variamis, Panayiotis Panayiotidis, Maria Bakiri, Themistoklis Karmiris, Georgios Z. Rassidakis, Paolo Corradini, Gerassimos Pangalis, Simonetta Viviani
Publikováno v:
HemaSphere, Vol 6, Pp 53-53 (2022)
Externí odkaz:
https://doaj.org/article/9af2f4353535489f97c76a2d794893b2
Autor:
Federico Lussana, Chiara Francesca Magnani, Giuseppe Gaipa, Stefania Galimberti, Giuseppe Gritti, Daniela Belotti, Sara Napolitano, Chiara Buracchi, Gian Maria Borleri, Benedetta Rambaldi, Giuliana Rizzuto, Anna Grassi, Muriel Paganessi, Silvia Ferrari, Sarah Tettamanti, Giovanni Gazzaniga, Chiara Capelli, Elisa Gotti, Martino Introna, Adriana Balduzzi, Maria Grazia Valsecchi, Giuseppe Dastoli, Alessandro Rambaldi, Andrea Biondi
Publikováno v:
Blood. 140:4568-4569
Autor:
Benedetta Rambaldi, Stefania Galimberti, Giuliana Rizzuto, Chiara Francesca Magnani, Chiara Buracchi, Giulia Risca, Martina Paredi, Daniela Belotti, Alex Moretti, Marianna Ponzo, Sarah Tettamanti, Gian Maria Borleri, Cristian Meli, Muriel Paganessi, Silvia Zaninelli, Elisa Gotti, Chiara Capelli, Martino Introna, Federico Lussana, Giuseppe Gritti, Silvia Ferrari, Anna Grassi, Sara Napolitano, Adriana Balduzzi, Maria Grazia Valsecchi, Giuseppe Dastoli, Alessandro Rambaldi, Andrea Biondi, Giuseppe Gaipa
Publikováno v:
Blood. 140:10339-10340
Autor:
Paola Minetto, Carmela Gurreri, Fabio Guolo, Anna Candoni, Giovanni Rossi, Giambattista Bertani, Marco Cerrano, Patrizia Zappasodi, Francesco Grimaldi, Atto Bilio, Anna Maria Scattolin, Barbara Scappini, Pellegrino Musto, Marino Clavio, Agostino Tafuri, Livio Pagano, Crescenza Pasciolla, Giuseppe Pietrantuono, Monica Morselli, Alessandro Cignetti, Roberto M. Lemoli, Sara Galimberti, Ernesta Audisio, Nicola Stefano Fracchiolla, Fabrizio Carnevale-Schianca, Felicetto Ferrara, Stefano D'Ardia, Giuseppe Rossi, Francesca Pavesi, Manuela Caizzi, Michele Gottardi, Luana Fianchi, Giuliana Rizzuto, Michela Rondoni, Michela Dargenio, Caterina Alati
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 10, Iss 10, Pp 1-11 (2020)
Blood Cancer Journal, Vol 10, Iss 10, Pp 1-11 (2020)
Secondary acute myeloid leukemia (sAML) poorly responds to conventional treatments and allogeneic stem cell transplantation (HSCT). We evaluated toxicity and efficacy of CPX-351 in 71 elderly patients (median age 66 years) with sAML enrolled in the I
Autor:
Cerrano Marco, Anna Maria Scattolin, Francesca Pavesi, Pellegrino Musto, Marino Clavio, Agostino Tafuri, Margherita Sciumé, Roberto M. Lemoli, Nicola Stefano Fracchiolla, Crescenza Pasciolla, Anna Candoni, Giuseppe Rossi, Giuliana Rizzuto, Francesco Grimaldi, Fabrizio Carnevale Schianca, Giuseppe Pietrantuono, Michelina Dargenio, Felicetto Ferrara, Caterina Alati, Manuela Caizzi, Stefano D'Ardia, Michele Gottardi, Patrizia Zappasodi, Giambattista Bertani, Luana Fianchi, Ernesta Audisio, Paola Minetto, Fabio Guolo, Livio Pagano, Giovanni Rossi, Atto Billio, Carmela Gurrieri, Michela Rondoni, Barbara Scappini, Mauro Endri, Alessandro Cignetti, Sara Galimberti, Michele Cea, Monica Morselli
Publikováno v:
Blood. 138:1262-1262
Introduction: The outcome of patients with acute myeloid leukemia (AML) secondary to myelodisplastic syndrome (MDS) or therapy-related (t-AML) receiving conventional treatment and allogeneic stem cell transplantation consolidation (HSCT) is poor. CPX
Autor:
Giovanni Cazzaniga, Chiara F. Magnani, Gianluca Cavallaro, Giuseppe Gaipa, Giuseppe Dastoli, Gian Maria Borleri, Andrea Biondi, Sarah Tettamanti, Silvia Ferrari, Giuliana Rizzuto, Adriana Balduzzi, Federico Lussana, Maria Grazia Valsecchi, Giuseppe Gritti, Benedetta Rambaldi, Alessandro Rambaldi, Chiara Buracchi, Martino Introna, Sara Napolitano, Daniela Belotti, Silvia Zaninelli, Stefania Galimberti
Publikováno v:
Blood. 138:472-472
Introduction Allogeneic Chimeric Antigen Receptor (CAR) T cells engineered with non-viral methods offer a modality to reduce costs and logistical complexity of the viral process and allow lymphodepleted patients to access CAR T cell treatment. We rec
Autor:
Elisabetta Todisco, Nicola Fracchiolla, Cristina Papayannidis, Maria Paola Martelli, Giuliana Rizzuto, Alessandro Cignetti, Nicola Di Renzo, Patrizia Zappasodi, Michele Gottardi, Ernesta Audisio, Monia Lunghi, Federica Gigli, Corrado Tarella, Chiara Zingaretti, Elisabetta Petracci, Roberta Volpi, Delia Cangini, Maria Benedetta Giannini, Mariarita Sciumè, Giuseppe Rossi, Avalon Group, Giovanni Martinelli, Claudio Cerchione
Publikováno v:
Blood. 136:37-38
Background This non-interventional retrospective study, is intended to analyze toxicity and effectiveness of venetoclax of a large cohort of R/R and de novo AML patients treated in Italy since 2015 outside clinical trials with the ultimate goal of im